Precision Optics (POCI) Competitors $4.74 +0.02 (+0.32%) As of 03:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock POCI vs. TLSI, LAKE, AVR, PDEX, MBOT, LUCD, ICAD, NSPR, OBIO, and ZJYLShould you be buying Precision Optics stock or one of its competitors? The main competitors of Precision Optics include TriSalus Life Sciences (TLSI), Lakeland Industries (LAKE), Anteris Technologies Global (AVR), Pro-Dex (PDEX), Microbot Medical (MBOT), Lucid Diagnostics (LUCD), icad (ICAD), InspireMD (NSPR), Orchestra BioMed (OBIO), and Jin Medical International (ZJYL). These companies are all part of the "medical equipment" industry. Precision Optics vs. Its Competitors TriSalus Life Sciences Lakeland Industries Anteris Technologies Global Pro-Dex Microbot Medical Lucid Diagnostics icad InspireMD Orchestra BioMed Jin Medical International TriSalus Life Sciences (NASDAQ:TLSI) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings, risk and media sentiment. Which has more risk and volatility, TLSI or POCI? TriSalus Life Sciences has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500. Do analysts recommend TLSI or POCI? TriSalus Life Sciences currently has a consensus price target of $10.75, suggesting a potential upside of 135.95%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, research analysts plainly believe TriSalus Life Sciences is more favorable than Precision Optics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TriSalus Life Sciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25Precision Optics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders have more ownership in TLSI or POCI? 2.6% of TriSalus Life Sciences shares are owned by institutional investors. Comparatively, 13.7% of Precision Optics shares are owned by institutional investors. 27.5% of TriSalus Life Sciences shares are owned by insiders. Comparatively, 13.0% of Precision Optics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media favor TLSI or POCI? In the previous week, TriSalus Life Sciences had 10 more articles in the media than Precision Optics. MarketBeat recorded 11 mentions for TriSalus Life Sciences and 1 mentions for Precision Optics. Precision Optics' average media sentiment score of 1.88 beat TriSalus Life Sciences' score of 0.29 indicating that Precision Optics is being referred to more favorably in the news media. Company Overall Sentiment TriSalus Life Sciences Neutral Precision Optics Very Positive Which has preferable valuation & earnings, TLSI or POCI? Precision Optics has lower revenue, but higher earnings than TriSalus Life Sciences. Precision Optics is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTriSalus Life Sciences$29.43M5.86-$30.05M-$1.18-3.86Precision Optics$19.10M1.91-$2.95M-$0.89-5.33 Is TLSI or POCI more profitable? Precision Optics has a net margin of -32.84% compared to TriSalus Life Sciences' net margin of -86.61%. TriSalus Life Sciences' return on equity of 0.00% beat Precision Optics' return on equity.Company Net Margins Return on Equity Return on Assets TriSalus Life Sciences-86.61% N/A -116.50% Precision Optics -32.84%-54.03%-32.48% SummaryTriSalus Life Sciences beats Precision Optics on 11 of the 17 factors compared between the two stocks. Get Precision Optics News Delivered to You Automatically Sign up to receive the latest news and ratings for POCI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding POCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart POCI vs. The Competition Export to ExcelMetricPrecision OpticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$36.39M$6.94B$5.69B$9.81BDividend YieldN/A1.30%4.61%4.07%P/E Ratio-5.3325.5130.6725.54Price / Sales1.9172.91463.88116.75Price / CashN/A21.9738.2159.48Price / Book2.865.418.986.13Net Income-$2.95M$176.29M$3.25B$264.89M7 Day Performance0.32%14.49%4.75%2.74%1 Month Performance-5.59%11.08%6.74%3.14%1 Year Performance-9.62%9.78%30.55%25.31% Precision Optics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)POCIPrecision Optics0.7525 of 5 stars$4.75+0.3%N/A-11.6%$36.39M$19.10M-5.3380TLSITriSalus Life Sciences3.0674 of 5 stars$3.65+2.2%$10.75+194.5%-33.7%$138.12M$29.43M-3.26106News CoverageEarnings ReportAnalyst RevisionLAKELakeland Industries4.7931 of 5 stars$14.12+2.6%$26.00+84.1%-34.8%$134.28M$167.21M-4.692,100Positive NewsAVRAnteris Technologies GlobalN/A$3.71+6.0%$16.50+344.7%N/A$133.78M$2.70M0.00138News CoverageEarnings ReportPDEXPro-Dex3.1263 of 5 stars$39.42+2.6%$56.00+42.1%+118.1%$128.51M$53.84M14.08140Positive NewsHigh Trading VolumeMBOTMicrobot Medical1.6456 of 5 stars$3.12+8.0%$9.00+188.5%+216.2%$113.51MN/A-4.8020News CoverageEarnings ReportLUCDLucid Diagnostics1.9561 of 5 stars$1.000.0%$3.55+255.9%+19.0%$107.92M$4.35M-0.7470News CoverageAnalyst ForecastICADicadN/A$3.87flatN/AN/A$106.31M$19.61M-20.37140NSPRInspireMD3.5856 of 5 stars$2.52-2.3%$4.50+78.6%-13.8%$105.14M$7.07M-3.3650OBIOOrchestra BioMed3.4062 of 5 stars$2.72+7.9%$14.00+414.7%-52.0%$105.10M$2.64M-1.534News CoverageEarnings ReportAnalyst ForecastZJYLJin Medical InternationalN/A$0.64-2.0%N/A-81.7%$99.64M$23.50M0.00245News CoveragePositive NewsShort Interest ↓ Related Companies and Tools Related Companies TLSI Alternatives LAKE Alternatives AVR Alternatives PDEX Alternatives MBOT Alternatives LUCD Alternatives ICAD Alternatives NSPR Alternatives OBIO Alternatives ZJYL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:POCI) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precision Optics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precision Optics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.